Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition. results from the TARGET trial

✍ Scribed by M.J Ross; H.C Herrmann; D.J Moliterno

• Book ID: 113413818
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 36 KB
• Volume: 13
• Category: Article
• ISSN: 1062-1458
• DOI: 10.1016/j.accreview.2003.10.049